EF
VKTX icon

Empowered Funds’s Viking Therapeutics VKTX Stock Holding History

Empowered Funds’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Sell
9,820
-399
-4% -$12.9K ﹤0.01% 1772
2026
Q1 		$333K Sell
10,219
-192
-2% -$6.17K ﹤0.01% 1783
2025
Q4 		$366K Buy
10,411
+683
+7% +$24.2K 0.01% 821
2025
Q3 		$256K Buy
9,728
+81
+0.8% +$2.42K ﹤0.01% 1647
2025
Q2 		$256K Buy
+9,647
New +$254K ﹤0.01% 1569
2025
Q1 		– Sell
-420
Closed -$16.9K – 1803
2024
Q4 		$16.9K Buy
+420
New +$23.9K ﹤0.01% 1647

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Empowered Funds's VKTX Position: Q2 2026 in Review

Empowered Funds reduced its Viking Therapeutics (VKTX) stake by 3.9% in Q2 2026, selling an estimated $12.9K and leaving 9,820 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.

Empowered Funds first reported a position in VKTX in Q4 2024 and has held it in 6 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Empowered Funds held 9,820 shares of Viking Therapeutics worth $383K as of Q2 2026.
  • Empowered Funds sold 399 Viking Therapeutics shares in Q2 2026, an estimated $12.9K.
  • Viking Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1772 holding.
  • Empowered Funds first reported a position in Viking Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.